21 reports

Kevzara®(sarilumab) Injection In May 2017, the FDA approved Kevzara for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have an inadequate response or intolerance to one or more disease modifying anti-rheumatic drugs (DMARDs).

  • Immunotherapy
  • Insulin
  • Respiratory Disease
  • Stroke
  • Regeneron Pharmaceuticals, Inc.

One unit consists of one disposable insulin pump.

  • Insulin
  • Insulin Delivery
  • Respiratory Disease
  • Stroke
  • Roche Group

The prominent features of this report are - ##.

  • Drug Development
  • Respiratory Disease
  • Stroke
  • World
  • Otsuka Pharmaceutical Co., Ltd.

The prominent features of this report are - ##.

  • Drug Development
  • Respiratory Disease
  • Stroke
  • World
  • Otsuka Pharmaceutical Co., Ltd.

One unit refers to one disposable insulin pen.

  • Insulin
  • Pharmaceutical
  • Respiratory Disease
  • Stroke
  • Pfizer Inc.

Similarly, the universities portfolio in Preclinical and Discovery stages comprises ## and ## molecules, respectively.

  • Insulin
  • Respiratory Disease
  • Stroke
  • United States
  • Product Initiative

One external remote patient monitoring device consists of one external module or transmitter.

  • Insulin
  • Pharmaceutical
  • Respiratory Disease
  • Stroke
  • United States

One unit refers to one disposable insulin pen.

  • Insulin
  • Pharmaceutical
  • Respiratory Disease
  • Stroke
  • Sanofi S.A.

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Asthma
  • Insulin
  • Respiratory Disease
  • Stroke
  • AstraZeneca PLC
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd ## ## ## ## ## ## ## Celgene Corp ## ## ## ## ## ## ## C.

  • Clinical Trial
  • Medical Biotechnology
  • Respiratory Disease
  • World
  • Product Initiative

FURTHERMORE, CGEN-## SHOWED EFFICACY SIMILAR TO THAT OBSERVED THROUGH TNF-ALPHA BLOCKADE WITH TNFR-FC, ENBREL, A WIDELY USED BIOLOGIC DISEASE MODIFYING ANTI-RHEUMATIC DRUG (DMARD).

  • Insulin
  • Respiratory Disease
  • Stroke
  • United States
  • Company

FRANZ KOHLER CHEMIE GMBH CYTACOAT AB ENDACEA INC ENLIVEX THERAPEUTICS LTD ENZYCHEM LIFESCIENCES CORP EUNOIA BIOTECH LLC EXOXEMIS INC EXPRESSION DRUG DESIGNS LLC GPN VACCINES PVT LTD HIBERNAID INC ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Blood Disease
  • Insulin
  • Respiratory Disease
  • Stroke
  • Bristol-Myers Squibb Company

FRANZ KOHLER CHEMIE GMBH ENDACEA INC ENLIVEX THERAPEUTICS LTD ENZYCHEM LIFESCIENCES CORP EUNOIA BIOTECH LLC EVEC INC EXPRESSION DRUG DESIGNS LLC GPN VACCINES PVT LTD P III ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P II ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Un ## ## ## ## ## ## ## ## ## ## ##

  • Blood Disease
  • Insulin
  • Respiratory Disease
  • Stroke
  • Bristol-Myers Squibb Company

They act by targeting serum chitotriosidase ## (CHIT-##).

  • Insulin
  • Research And Development
  • Respiratory Disease
  • Stroke
  • AstraZeneca PLC
  • STROKE - PIPELINE BY SAVARA INC, H1 2018
  • STROKE - PIPELINE BY SHIN POONG PHARMCO LTD, H1 2018

The company provides cardiovascular, psychoneurotic, anti-cancer, antihistamine, antirheumatic and benign prostatic hyperplasia drugs.

  • Insulin
  • Respiratory Disease
  • Stroke
  • Company
  • Product Initiative
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H1 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Chronic Disease
  • Insulin
  • Respiratory Disease
  • Stroke
  • AB Science SA
  • ACUTE ISCHEMIC STROKE - PIPELINE BY SIMCERE PHARMACEUTICAL GROUP, H2 2016

In August 2011, AB Science registered a Phase II/ III multicenter, randomized, double-blind, controlled, ##-parallel groups study to compare efficacy and safety of masitinib at ## and ## mg/ kg/ day to methotrexate, with a randomization ##:##:##, in treatment of pati

  • Insulin
  • Respiratory Disease
  • Stroke
  • Product Initiative
  • AB Science SA

BUT IT IS ONE OF THE MOST IMPORTANT POINTS!

  • Insulin
  • Respiratory Disease
  • Stroke
  • Roche Group
  • Sandoz Inc.

Research and Development Brief The drug candidate has also been demonstrated in animal models of rheumatoid arthritis (RA), CDK## inhibitors lead to profound reduction of cellular infiltration into arthritis joints, suggesting a disease-modifying anti-rheumatic activity.

  • Insulin
  • Respiratory Disease
  • Stroke
  • United States
  • AstraZeneca PLC

The majority of the trial participants were on a stable regimen of disease modifying anti-rheumatic drugs.

  • Cancer
  • Insulin
  • Respiratory Disease
  • Stroke
  • GlaxoSmithKline plc